Literature DB >> 29323346

Inflammation in 2017: Connectivity to other fields brings new ideas.

Pierre Miossec1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29323346     DOI： 10.1038/nrrheum.2017.215

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.

Authors:  Jamie Robertson; Duncan Porter; Naveed Sattar; Chris J Packard; Muriel Caslake; Iain McInnes; David McCarey
Journal:  Ann Rheum Dis       Date:  2017-09-15       Impact factor: 19.103

2.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

3.  Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.

Authors:  Rakiba Belkhir; Sébastien Le Burel; Laetitia Dunogeant; Aurélien Marabelle; Antoine Hollebecque; Benjamin Besse; Alexandra Leary; Anne-Laure Voisin; Clémence Pontoizeau; Laetitia Coutte; Edouard Pertuiset; Gaël Mouterde; Olivier Fain; Olivier Lambotte; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2017-06-09       Impact factor: 19.103

4.  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn
Journal:  Lancet       Date:  2017-08-27       Impact factor: 79.321

5.  Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells.

Authors:  Arnaud Hot; Fabien Lavocat; Vanina Lenief; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2012-08-21       Impact factor: 19.103

6.  Regional analysis of p53 mutations in rheumatoid arthritis synovium.

Authors:  Yuji Yamanishi; David L Boyle; Sanna Rosengren; Douglas R Green; Nathan J Zvaifler; Gary S Firestein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

7.  Production of interleukin 1 by human endothelial cells.

Authors:  P Miossec; D Cavender; M Ziff
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier.

Authors:  Nicolas Dutzan; Loreto Abusleme; Hayley Bridgeman; Teresa Greenwell-Wild; Tamsin Zangerle-Murray; Mark E Fife; Nicolas Bouladoux; Holly Linley; Laurie Brenchley; Kelly Wemyss; Gloria Calderon; Bo-Young Hong; Timothy J Break; Dawn M E Bowdish; Michail S Lionakis; Simon A Jones; Giorgio Trinchieri; Patricia I Diaz; Yasmine Belkaid; Joanne E Konkel; Niki M Moutsopoulos
Journal:  Immunity       Date:  2017-01-10       Impact factor: 31.745

9.  PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints.

Authors:  Saw-See Hong; Hubert Marotte; Guillaume Courbon; Gary S Firestein; Pierre Boulanger; Pierre Miossec
Journal:  Nat Commun       Date:  2017-07-27       Impact factor: 14.919

10.  Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease.

Authors:  René Pfeifle; Tobias Rothe; Natacha Ipseiz; Hans U Scherer; Stephan Culemann; Ulrike Harre; Jochen A Ackermann; Martina Seefried; Arnd Kleyer; Stefan Uderhardt; Benjamin Haugg; Axel J Hueber; Patrick Daum; Gordon F Heidkamp; Changrong Ge; Sybille Böhm; Anja Lux; Wolfgang Schuh; Iryna Magorivska; Kutty S Nandakumar; Erik Lönnblom; Christoph Becker; Diana Dudziak; Manfred Wuhrer; Yoann Rombouts; Carolien A Koeleman; René Toes; Thomas H Winkler; Rikard Holmdahl; Martin Herrmann; Stephan Blüml; Falk Nimmerjahn; Georg Schett; Gerhard Krönke
Journal:  Nat Immunol       Date:  2016-11-07       Impact factor: 25.606
  10 in total
  1 in total

1.  Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus.

Authors:  Abel Suarez-Fueyo; Maria G Tsokos; Seung-Ki Kwok; Kayaho Maeda; Eri Katsuyama; Peter H Lapchak; George C Tsokos
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.